- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:42 | AstraZeneca 4Q Results | ||
| 16:42 | atai Acquires Psilera's DMT Patent Portfolio | ||
| 15:42 | Andelyn Biosciences Expands AAV Curator Platform Offering | ||
| 15:42 | Teva, Alvotech Launch SELARSDI, Stelara Biosimilar | ||
| 15:42 | Tiziana Life Sciences & Renaissance Partner on Nasal Foralumab Production | ||
| Do | Eleva Appoints New Chief Medical Officer | ||
| Do | Harbour BioMed & Insilico Partner on AI-Driven Antibody Discovery | ||
| Do | Thermo Fisher Scientific Launches NanoDrop Ultra | ||
| Do | Rentschler Biopharma Appoints Patrick Meyer Global Head of BD | ||
| Do | Boehringer Ingelheim Names Brian Hilberdink as President, U.S. Human Pharma | ||
| Do | BioMed X Launches Pilot Project in Barbados for Black Health Equity | ||
| Do | ACG Capsules Introduces Full Vegan Printed Capsules | ||
| Mi | Brexogen, BMI Korea Ink Exosome Therapy Licensing Deal | ||
| Mi | PTC's FA Drug Vatiquinone Gets FDA Priority Review | ||
| Mi | Biogen, Stoke Partner on Zorevunersen in Dravet Syndrome | ||
| Mi | Celonic Group, LINDIS Biotech Sign Manufacturing Service Agreement for Catumaxomab | ||
| Mi | YourBio Health Taps Paul Owen as CEO | ||
| Mi | FDA Grants Priority Review to Boehringer Ingelheim's NDA for Zongertinib | ||
| Di | Seqens Names Pascal Villemagne as CEO | ||
| Di | TekniPlex Names New CEO | ||
| Di | Arcus Regains Rights to Casdatifan | ||
| Di | FDA Accepts Alvotech's Eylea Biosimilar for Review | ||
| Di | Asahi Kasei Bioprocess America Names New President | ||
| Di | Flourish Research Acquires Diablo Clinical Research | ||
| Di | sBLA for Dupixent Accepted by FDA for Priority Review |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
